Published in

Springer Nature [academic journals on nature.com], Molecular Psychiatry, 3(25), p. 584-602, 2018

DOI: 10.1038/s41380-018-0118-1

Links

Tools

Export citation

Search in Google Scholar

Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia.

Journal article published in 2018 by Ida E. Sønderby, Eco J. C. de Geus, Greig I. de Zubicaray, Anouk den Braber, Sonja M. C. de Zwarte, Nhat Trung Doan, Derrek P. Hibar, Ómar Gústafsson, Nicola J. Armstrong, John Blangero, Dorret I. Boomsma, Janita Bralten, Sandra Martin Brevet, Hans-Richard Brattbak, Henry Brodaty and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractCarriers of large recurrent copy number variants (CNVs) have a higher risk of developing neurodevelopmental disorders. The 16p11.2 distal CNV predisposes carriers to e.g., autism spectrum disorder and schizophrenia. We compared subcortical brain volumes of 12 16p11.2 distal deletion and 12 duplication carriers to 6882 non-carriers from the large-scale brain Magnetic Resonance Imaging collaboration, ENIGMA-CNV. After stringent CNV calling procedures, and standardized FreeSurfer image analysis, we found negative dose-response associations with copy number on intracranial volume and on regional caudate, pallidum and putamen volumes (β = −0.71 to −1.37; P < 0.0005). In an independent sample, consistent results were obtained, with significant effects in the pallidum (β = −0.95, P = 0.0042). The two data sets combined showed significant negative dose-response for the accumbens, caudate, pallidum, putamen and ICV (P = 0.0032, 8.9 × 10−6, 1.7 × 109, 3.5 × 10−12 and 1.0 × 10−4, respectively). Full scale IQ was lower in both deletion and duplication carriers compared to non-carriers. This is the first brain MRI study of the impact of the 16p11.2 distal CNV, and we demonstrate a specific effect on subcortical brain structures, suggesting a neuropathological pattern underlying the neurodevelopmental syndromes.